Company: DNLI
Filing Date: 2025-06-03
Form Type: 8-K
Source: 0001714899-25-000128
Chunk: 3

Company: Denali Therapeutics Inc.
Filing Date: 2025-06-03
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                                                
         10.1      Affiliate Registration Rights Agreement, dated June 3, 2025, by and among the Company, Baker Brothers Life Sciences, L. P. and 667, L. P.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (formatted as Inline XBRL)                                                                                

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               DENALI THERAPEUTICS INC.                                             
  Date:      June 3, 2025      By:                           /s/ Alexander O. Schuth                
                                                             Alexander O. Schuth, M. D.             
                                                             Chief Operating and Financial Officer